VSIG8 Antibody (961823) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB9418JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG1 Clone # 961823
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell line HEK293-derived transfected with human VSIG8
Met1-Gly263
Accession # Q5VU13
Met1-Gly263
Accession # Q5VU13
Specificity
Detects human VSIG8 in direct ELISAs. Stains human VSIG8 transfectants but not irrelevant transfectants in flow cytometry.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for VSIG8 Antibody (961823) [Janelia Fluor® 669]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VSIG8
Long Name
V-Set and Immunoglobulin Domain Containing 8
Alternate Names
V-set and immunoglobulin domain containing 8
Additional VSIG8 Products
Product Documents for VSIG8 Antibody (961823) [Janelia Fluor® 669]
Product Specific Notices for VSIG8 Antibody (961823) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...